293 related articles for article (PubMed ID: 23907016)
1. 17β-estradiol promotes the invasion and migration of nuclear estrogen receptor-negative breast cancer cells through cross-talk between GPER1 and CXCR1.
Jiang QF; Wu TT; Yang JY; Dong CR; Wang N; Liu XH; Liu ZM
J Steroid Biochem Mol Biol; 2013 Nov; 138():314-24. PubMed ID: 23907016
[TBL] [Abstract][Full Text] [Related]
2. GPER/ERK&AKT/NF-κB pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells.
Zhu P; Liao LY; Zhao TT; Mo XM; Chen GG; Liu ZM
Mol Cell Endocrinol; 2017 Feb; 442():68-80. PubMed ID: 27940299
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
[TBL] [Abstract][Full Text] [Related]
5. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
Zhou K; Sun P; Zhang Y; You X; Li P; Wang T
Steroids; 2016 Jul; 111():113-120. PubMed ID: 26850467
[TBL] [Abstract][Full Text] [Related]
6. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.
Yang F; Xie HY; Yang LF; Zhang L; Zhang FL; Liu HY; Li DQ; Shao ZM
Autophagy; 2020 Jun; 16(6):1061-1076. PubMed ID: 32401166
[TBL] [Abstract][Full Text] [Related]
8. ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells.
Notas G; Panagiotopoulos A; Vamvoukaki R; Kalyvianaki K; Kiagiadaki F; Deli A; Kampa M; Castanas E
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299224
[TBL] [Abstract][Full Text] [Related]
9. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
10. 17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1.
François CM; Wargnier R; Petit F; Goulvent T; Rimokh R; Treilleux I; Ray-Coquard I; Zazzu V; Cohen-Tannoudji J; Guigon CJ
Carcinogenesis; 2015 May; 36(5):564-73. PubMed ID: 25823895
[TBL] [Abstract][Full Text] [Related]
11. The Glycolytic Enzyme PFKFB3 Is Involved in Estrogen-Mediated Angiogenesis via GPER1.
Trenti A; Tedesco S; Boscaro C; Ferri N; Cignarella A; Trevisi L; Bolego C
J Pharmacol Exp Ther; 2017 Jun; 361(3):398-407. PubMed ID: 28348059
[TBL] [Abstract][Full Text] [Related]
12. Interplay of estrogen receptors and GPR30 for the regulation of early membrane initiated transcriptional effects: A pharmacological approach.
Notas G; Kampa M; Pelekanou V; Castanas E
Steroids; 2012 Aug; 77(10):943-50. PubMed ID: 22138208
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
Broselid S; Cheng B; Sjöström M; Lövgren K; Klug-De Santiago HL; Belting M; Jirström K; Malmström P; Olde B; Bendahl PO; Hartman L; Fernö M; Leeb-Lundberg LM
Clin Cancer Res; 2013 Apr; 19(7):1681-92. PubMed ID: 23554355
[TBL] [Abstract][Full Text] [Related]
14. Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1.
Qi M; Liu X; Zhou Y; Wang H; Zhao Y; Ren J; Xiang J
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768896
[TBL] [Abstract][Full Text] [Related]
15. The Interplay of GPER1 with 17β-Aminoestrogens in the Regulation of the Proliferation of Cervical and Breast Cancer Cells: A Pharmacological Approach.
Segovia-Mendoza M; Mirzaei E; Prado-Garcia H; Miranda LD; Figueroa A; Lemini C
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231664
[TBL] [Abstract][Full Text] [Related]
16. Heregulin-β1-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2/ErbB3-MAPK/ERK pathway.
Ruan SQ; Wang ZH; Wang SW; Fu ZX; Xu KL; Li DB; Zhang SZ
Biochem Biophys Res Commun; 2012 Apr; 420(2):385-90. PubMed ID: 22425775
[TBL] [Abstract][Full Text] [Related]
17. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
18. Baicalein suppresses 17-β-estradiol-induced migration, adhesion and invasion of breast cancer cells via the G protein-coupled receptor 30 signaling pathway.
Shang D; Li Z; Zhu Z; Chen H; Zhao L; Wang X; Chen Y
Oncol Rep; 2015 Apr; 33(4):2077-85. PubMed ID: 25672442
[TBL] [Abstract][Full Text] [Related]
19. Ceramide synthases CerS4 and CerS5 are upregulated by 17β-estradiol and GPER1 via AP-1 in human breast cancer cells.
Wegner MS; Wanger RA; Oertel S; Brachtendorf S; Hartmann D; Schiffmann S; Marschalek R; Schreiber Y; Ferreirós N; Geisslinger G; Grösch S
Biochem Pharmacol; 2014 Dec; 92(4):577-89. PubMed ID: 25451689
[TBL] [Abstract][Full Text] [Related]
20. Role of aromatase activation on sodium arsenite-induced proliferation, migration, and invasion of MDA-MB-231 and MDA-MB-453 breast cancer cell lines.
Reyes-Vázquez L; Hernández AJA; Calderón-Aranda ES
Toxicology; 2020 May; 437():152440. PubMed ID: 32197950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
